New Phase 3 clinical trials: 3,721 posted since Nov 2024

Name: New Phase 3 clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Phase 3 clinical trials: 3,721 rows for $117.21, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 166 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, enrollment type, location countries and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/phase/phase-3, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

3,721 clinical studies in phase 3 were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 2,047 have an industry sponsor and 2,906 are recruiting or about to. The newest, NCT07926048, was posted on November 9, 2026: A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (Qilu Pharmaceutical Co., Ltd.).

The request: Every new Phase 3 clinical trials on ClinicalTrials.gov, with the sponsor, conditions, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

3,721New trials
2,047Industry sponsored
2,906Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 3,721, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926048	A Study of QLS5132 in Platinum-Resistant Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Qilu Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer	420		clinicaltrials.gov
November 9, 2026	NCT07925398	Hetrombopag for Thrombocytopenia in Patients Scheduled for Elective Hepatic Interventional Diagnostic and Therapeutic Procedures: A...	Zhongda Hospital	Phase 3	Not yet recruiting	Thrombocytopenia, Hepatic Interventional Procedure	108		clinicaltrials.gov
November 9, 2026	NCT07925190	A Phase III Study Comparing Mesutoclax + Azacitidine Versus Venetoclax + Azacitidine in Untreated Acute Myeloid Leukemia (AML) Patients	Beijing InnoCare Pharma Tech Co., Ltd.	Phase 3	Not yet recruiting	Acute Myeloblastic Leukaemia	318	China	clinicaltrials.gov
November 9, 2026	NCT07925021	A Study of SYS6010 Combined With Enlonstobart in Patients With Previously Systemic Treatment-Naive R/M Nasopharyngeal Carcinoma	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 3	Recruiting	Previously Systemic Treatment-Naive Recurrent or Metastatic Nasopharyngeal Carcinoma	424	China	clinicaltrials.gov
November 9, 2026	NCT07924111	A Randomized, Controlled, Double-Blind, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Enlonstobart, With or...	CSPC Megalith Biopharmaceutical Co.,Ltd.	Phase 3	Not yet recruiting	Esophageal Squamous Cell Carcinoma	585		clinicaltrials.gov
November 9, 2026	NCT07924059	Phase 3 Clinical Trial Evaluating the Efficacy and Safety of Navepegritide and Lonapegsomatropin in Achondroplasia	Ascendis Pharma A/S	Phase 3	Not yet recruiting	Achondroplasia	144		clinicaltrials.gov
November 9, 2026	NCT07923981	A Study to Assess the Safety of Marstacimab and How Well it Works in People With Mild to Moderate Hemophilia A or B Without Inhibitors	Pfizer	Phase 3	Recruiting	Hemophilia A or B	95	United States	clinicaltrials.gov
November 6, 2026	NCT07922863	MUTTON-HF Pilot Expansion	University of Pennsylvania	Phase 3	Not yet recruiting	Heart Failure	100		clinicaltrials.gov
November 6, 2026	NCT07922460	Anti-VEGF Versus Prompt Laser or Observation for Proliferative Sickle Cell Retinopathy (ALPS)	University of Illinois Chicago	Phase 3	Not yet recruiting	Proliferative Sickle Cell Retinopathy	50	United States	clinicaltrials.gov
November 6, 2026	NCT07922330	A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These...	AstraZeneca	Phase 3	Not yet recruiting	Obesity, Overweight, Type 2 Diabetes Mellitus	330	China, India	clinicaltrials.gov
November 6, 2026	NCT07920939	Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes	Jiangsu HengRui Medicine Co., Ltd.	Phase 3	Not yet recruiting	Type 2 Diabetes	450	China	clinicaltrials.gov
November 5, 2026	NCT07919938	Submucosal Cryotherapy and Anti-inflammatory Drugs for Postoperative Pain Following Root Canal Treatment in Maxillary Molars	Suez Canal University	Phase 3	Not yet recruiting	Pulpitis	90	Egypt	clinicaltrials.gov
November 5, 2026	NCT07919899	Pharmacokinetics, Immunogenicity and Safety of Subcutaneous Dupilumab and Berahyaluronidase Alfa (ALT-B4) Coformulation	Sanofi	Phase 3	Not yet recruiting	Dermatitis Atopic	150		clinicaltrials.gov
November 5, 2026	NCT07919886	Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of...	Cairo University	Phase 3	Not yet recruiting	Acne, Acne Papulopustulosa	24	Egypt	clinicaltrials.gov
November 5, 2026	NCT07919678	A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)	Pfizer	Phase 3	Recruiting	Obesity, Overweight, Osteoarthritis of the Knee	656	Canada, United States	clinicaltrials.gov
November 5, 2026	NCT07919405	A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Hypertension, Obesity	1,408	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany...	clinicaltrials.gov
November 5, 2026	NCT07918846	A Clinical Study Testing Enicepatide in Participants Living With Overweight or Obesity and Cardiovascular Disease	Hoffmann-La Roche	Phase 3	Not yet recruiting	Overweight, Obesity, Cardiovascular Disease	8,200		clinicaltrials.gov
November 5, 2026	NCT07918222	Sequential Treatment Approaches for Treatment-Resistant Schizophrenia	Shanghai Mental Health Center	Phase 3	Recruiting	Treatment-resistant Schizophrenia	300	China	clinicaltrials.gov
November 5, 2026	NCT07917806	A RCT of Collagen Scaffold for the Repair of Talus Cartilage Injury	Beijing Jishuitan Hospital	Phase 3	Enrolling by invitation	Cartilage Defects, Talus Osteochondral Defect	40	China	clinicaltrials.gov
November 4, 2026	NCT07917507	A Study to Assess the Efficacy of Two Brushing Regimens in the Reduction of Established Dental Plaque and Gingivitis	Colgate Palmolive	Phase 3	Active not recruiting	Plaque, Gingivitis	84	Dominican Republic	clinicaltrials.gov
November 4, 2026	NCT07917468	Sintilimab Combined With LCCRT Followed by Capeox Chemotherapy in pMMR/MSS/MSI-L Locally Advanced Rectal Cancer	Innovent Biologics (Suzhou) Co. Ltd.	Phase 3	Not yet recruiting	Locally Advanced Rectal Cancer	500	China	clinicaltrials.gov
November 4, 2026	NCT07917247	Safety and Efficacy of Secukinumab Versus Mycophenolate Mofetil in Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-associated...	Chinese PLA General Hospital	Phase 3	Not yet recruiting	Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)	130		clinicaltrials.gov
November 4, 2026	NCT07917143	A Clinical Trial to Evaluate Efficacy and Safety of Navepegritide Versus Placebo in Children and Adolescents With Hypochondroplasia	Ascendis Pharma A/S	Phase 3	Not yet recruiting	Hypochondroplasia	81		clinicaltrials.gov
November 4, 2026	NCT07917078	Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk Features	China National Center for Cardiovascular Diseases	Phase 3	Not yet recruiting	Pulmonary Embolism	270	China	clinicaltrials.gov
November 4, 2026	NCT07916922	Assessment of The Potential Therapeutic Effects of Trimetazidine on Aluminium Phosphide-Induced Cardiotoxicity as an Adjuvant Therapy: A...	Ain Shams University	Phase 3	Recruiting	Aluminum Phosphide Poisoning	20	Egypt	clinicaltrials.gov
November 4, 2026	NCT07916844	Hepatic Arterial Infusion Chemotherapy Versus Capecitabine as Adjuvant Therapy for Resected Biliary Tract Cancer	Zhai Wenlong	Phase 3	Not yet recruiting	Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer	90	China	clinicaltrials.gov
November 4, 2026	NCT07916480	Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis	Arcutis Biotherapeutics, Inc.	Phase 3	Recruiting	Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)	415	United States	clinicaltrials.gov
November 4, 2026	NCT07916259	The Study of Brave-LC LDN Treatment Trial	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3	Not yet recruiting	Post-acute COVID-19 Syndrome	1,300	United States	clinicaltrials.gov
November 4, 2026	NCT07915739	Internal Mammary Node Irradiation After Neoadjuvant Systemic Therapy for Breast Cancer	Mahidol University	Phase 3	Not yet recruiting	Breast Neoplasms	1,760	Thailand	clinicaltrials.gov
November 4, 2026	NCT07915609	A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With or Without Type 2...	Pfizer	Phase 3	Recruiting	Obesity, Overweight and/or Obesity, Knee Osteoarthritis, Diabetes Melliuts, Type 2	756	United States	clinicaltrials.gov
November 4, 2026	NCT07915518	A Phase III Trial to Evaluate the Safety and Efficacy of Anti-inflammatory Drugs in Addition to Praziquantel in Girls and Women With Female...	Brian Ngwira	Phase 3	Not yet recruiting	Female Genital Schistosomiasis	800	Côte d’Ivoire, Democratic Republic of the Congo, Ghana, Malawi	clinicaltrials.gov
November 4, 2026	NCT07915388	Comparative Study of Post-Varicocelectomy Myo-inositol vs. Antioxidants vs. Surgery Alone in Infertile Men	Fayoum University Hospital	Phase 3	Not yet recruiting	Myo-inositol, Post Varicocelectomy, Infertile Men, Varicocele	150	Egypt	clinicaltrials.gov
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
November 4, 2026	NCT07915037	Evaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With...	Assistance Publique - Hôpitaux de Paris	Phase 3	Not yet recruiting	Metastasic NSCLC	254	France	clinicaltrials.gov
November 4, 2026	NCT07914894	A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Phase 3	Not yet recruiting	Paroxysmal Nocturnal Hemoglobinuria	20	China	clinicaltrials.gov
November 3, 2026	NCT07914101	Sequential Chemotherapy Followed by Ultrahypofractionated Radiotherapy for Muscle-Invasive Bladder Cancer	Assiut University	Phase 3	Not yet recruiting	Bladder Cancer, TURBT, Radiotherapy	71		clinicaltrials.gov
November 3, 2026	NCT07913360	GFH375 Plus Cetuximab vs Investigator's Choice of Treatment in KRAS G12D-Mutant Refractory Metastatic Colorectal Cancer	Genfleet Therapeutics (Shanghai) Inc.	Phase 3	Not yet recruiting	Colorectal Cancer	368		clinicaltrials.gov
November 3, 2026	NCT07913061	A Study Comparing SHR-3167 With Insulin Degludec in Adults With Type 2 Diabetes Currently Treated With Basal Insulin	Jiangsu HengRui Medicine Co., Ltd.	Phase 3	Not yet recruiting	Diabetes Mellitus, Type 2	680	China	clinicaltrials.gov
November 3, 2026	NCT07912970	Tenecteplase Bridging Thrombolysis Prior to Inter-hospital Transfer for Endovascular Therapy in Anterior Circulation Large Vessel Occlusion...	Fujian Medical University Union Hospital	Phase 3	Not yet recruiting	Acute Ischemic Stroke, Large Vessel Occlusion	1,266	China	clinicaltrials.gov
November 3, 2026	NCT07912398	HMPL-306 in Participants With Postoperative Residual or Recurrent Grade 2 Glioma Harboring IDH1 or IDH2 Mutations	Hutchmed	Phase 3	Not yet recruiting	Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation	210		clinicaltrials.gov
November 3, 2026	NCT07911800	rhTPO for Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Procedures.	MIBIO PTE. LTD.	Phase 3	Recruiting	Thrombocytopenia Associated With Chronic Liver Disease	150	Georgia	clinicaltrials.gov
November 3, 2026	NCT07911787	Phase 3 Study of HS-10380 for Acute Schizophrenia in Chinese Adults	Jiangsu Hansoh Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	SCHIZOPHRENIA 1 (Disorder)	476	China	clinicaltrials.gov
November 2, 2026	NCT07911553	A Study to Evaluate Surovatamig Combined With R-CHOP in Participants of 18 to < 80 Years of Age With Previously Untreated Large B-cell...	AstraZeneca	Phase 3	Not yet recruiting	Large B-cell Lymphoma	1,200		clinicaltrials.gov
November 2, 2026	NCT07910903	Study of CM336+CM313 Combination Therapy in Patients With Relapsed or Refractory Multiple Myeloma	Keymed Biosciences Co.Ltd	Phase 3	Not yet recruiting	Multiple Myeloma (MM)	320	China	clinicaltrials.gov
November 2, 2026	NCT07910760	TRINITY TRIAL; Trial Of PRRT Plus CAPTEM Vs CAPTEM Alone In Well Differentiated GEP NETS	Tata Memorial Hospital	Phase 3	Not yet recruiting	Gastroenteropancreatic Neuroendocrine Tumors	123		clinicaltrials.gov
November 2, 2026	NCT07909902	A Clinical Trial of Local Infiltration With Injection CZ1S for Postoperative Analgesia After Hemorrhoidectomy	Zhejiang Cuize Pharmaceutical Technology Co., Ltd.	Phase 3	Completed	Hemorrhoids Second Degree, Hemorrhoids Third Degree, Analgesia	243	China	clinicaltrials.gov
November 2, 2026	NCT07908875	Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.	First Affiliated Hospital of Wannan Medical College	Phase 3	Not yet recruiting	Ischemia Stroke, TIA (Transient Ischemic Attack)	520		clinicaltrials.gov
November 2, 2026	NCT07908745	Reduced-Dose vs Standard-Dose Thoracic Radiotherapy After Induction Chemoimmunotherapy in Older or Frail Stage III NSCLC	Ruijin Hospital	Phase 3	Not yet recruiting	Non-Small-Cell Lung Cancer	276		clinicaltrials.gov
November 2, 2026	NCT07908732	Risk-Adapted Segmental Esophagus-Sparing Radiotherapy for Definitive Non-Small Cell Lung Cancer	Ruijin Hospital	Phase 3	Not yet recruiting	Non-Small Cell Lung Cancer	140		clinicaltrials.gov
November 2, 2026	NCT07908654	A Study to Evaluate Efficacy, Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Older Adults Aged 60 Years...	Guangzhou Patronus Biotech Co., Ltd.	Phase 3	Not yet recruiting	Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus (RSV) Infection, RSV Vaccine	25,000	China	clinicaltrials.gov
November 2, 2026	NCT07908537	A Clinical Trial of Gocatamig (MK-6070) With Durvalumab in Participants With Small Cell Lung Cancer (MK-6070-004)	Merck Sharp & Dohme LLC	Phase 3	Not yet recruiting	Small Cell Lung Cancer	564		clinicaltrials.gov
October 30, 2026	NCT07908082	Aspirin for the Prevention of Ischemic Complications in Giant Cell Arteritis	Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal	Phase 3	Not yet recruiting	Giant Cell Arteritis (GCA), Acute Coronary Syndrome (ACS), Ishemic and Thrombotic Complications	120	Canada	clinicaltrials.gov
October 30, 2026	NCT07907991	The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease	Boehringer Ingelheim	Phase 3	Not yet recruiting	Chronic Obstructive Pulmonary Disease	1,800		clinicaltrials.gov
October 30, 2026	NCT07906717	A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer	Janssen Research & Development, LLC	Phase 3	Recruiting	Prostatic Neoplasms	400	Israel, United States	clinicaltrials.gov
October 30, 2026	NCT07906275	INTRA-ARTERIAL MeVO TREATMENT (IMP-ACT) Within the ACT-GLOBAL Adaptive Platform Trial-NCT06352632	University of Calgary	Phase 3	Not yet recruiting	Stroke, Acute Ischemic, Medium Vessel Occlusion	800	Canada	clinicaltrials.gov
October 29, 2026	NCT07905183	A Randomized Study of ELVN-001 Versus Investigator-Selected TKI, in CP-CML Previously Treated With One or More TKIs	Enliven Therapeutics	Phase 3	Not yet recruiting	Chronic Myeloid Leukemia (CML), Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive, Chronic Phase Chronic...	450		clinicaltrials.gov
October 29, 2026	NCT07904910	Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial...	Cairo University	Phase 3	Recruiting	Vitiligo, Non-Segmental Vitiligo (NSV), Stable Vitiligo	35	Egypt	clinicaltrials.gov
October 29, 2026	NCT07904533	Efficacy and Safety of Minocycline Add-on in Patients With Neurosyphilis	Beijing Ditan Hospital	Phase 3	Not yet recruiting	Neurosyphilis	778	China	clinicaltrials.gov
October 29, 2026	NCT07904429	Keverprazan-Minocycline Dual Therapy of Different Durations Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.	Nanjing First Hospital, Nanjing Medical University	Phase 3	Recruiting	Helicobacter Infection	612	China	clinicaltrials.gov
October 29, 2026	NCT07904195	Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063.	Inmunotek S.L.	Phase 3	Recruiting	Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma	250	Portugal, Spain	clinicaltrials.gov
October 29, 2026	NCT07904156	A Phase III Randomized Controlled Trial of Serplulimab Plus Fruquintinib as Adjuvant Therapy for High-Risk Non-Clear Cell Renal Cell...	Sun Yat-sen University	Phase 3	Not yet recruiting	Non-Clear Cell Renal Cell Carcinoma (nccRCC)	108		clinicaltrials.gov
October 29, 2026	NCT07904052	Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.	Inmunotek S.L.	Phase 3	Recruiting	Allergic Rhinitis, Allergic Rhinoconjunctivitis, Allergic Asthma	250	Portugal, Spain	clinicaltrials.gov
October 29, 2026	NCT07903506	To Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma	Kite, A Gilead Company	Phase 3	Not yet recruiting	Newly Diagnosed Multiple Myeloma	750		clinicaltrials.gov
October 29, 2026	NCT07903272	A Trial Comparing Ramantamig and Daratumumab (Ramantamig-D) Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Participants...	Janssen Research & Development, LLC	Phase 3	Not yet recruiting	Multiple Myeloma	1,000		clinicaltrials.gov
October 29, 2026	NCT07903194	A Study to Evaluate the Efficacy and Safety of MG-K10 in Adults With Chronic Rhinosinusitis With Nasal Polyps	Shanghai Mabgeek Biotech.Co.Ltd	Phase 3	Not yet recruiting	Chronic Rhinosinusitis With Nasal Polyps	210		clinicaltrials.gov
October 29, 2026	NCT07902999	HB0025-C-0301: A Study to Investigate HB0025 Combined With Chemotherapy as First-Line Treatment for Advanced or Recurrent MMR-proficient...	Shanghai Huaota Biopharmaceutical Co., Ltd.	Phase 3	Recruiting	First-line pMMR Endometrial Cancer	333	China	clinicaltrials.gov
October 29, 2026	NCT07902817	A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy	Jade Biosciences, Inc.	Phase 3	Recruiting	IgA Nephropathy (IgAN)	480	United States	clinicaltrials.gov
October 29, 2026	NCT07902791	Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau	Phase 3	Recruiting	Acute Ischemic Stroke, Large Vessel Occlusion	314	Spain	clinicaltrials.gov
October 28, 2026	NCT07901894	Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea	Laboratorios Silanes S.A. de C.V.	Phase 3	Completed	Primary Dysmenorrhea	130	Mexico	clinicaltrials.gov
October 28, 2026	NCT07901842	Recombinant Human Prourokinase for Acute Ischemic Stroke in the Extended Window Selected by CT-Based Artificial Intelligence	Second Affiliated Hospital, Zhejiang University, School of Medicine	Phase 3	Not yet recruiting	Acute Ischemic Stroke	826	China	clinicaltrials.gov
October 28, 2026	NCT07901738	Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children	Precigen, Inc	Phase 3	Not yet recruiting	Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis, Papillomavirus...	15	United States	clinicaltrials.gov
October 28, 2026	NCT07901725	Linvoseltamab Versus Daratumumab, Bortezomib, Cyclophosphamide, and Dexamethasone (Dara-Vcd) in Adult Participants With Newly Diagnosed...	Regeneron Pharmaceuticals	Phase 3	Not yet recruiting	Newly Diagnosed Amyloidosis, Amyloidosis Stage I-IIIA	382		clinicaltrials.gov
October 28, 2026	NCT07900789	HRS-4642 Combined With Antitumor Agents for the Treatment of Perioperative Pancreatic Cancer	Shanghai Hengrui Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	Systemic Treatment-naïve Pancreatic Cancer	825	China	clinicaltrials.gov
October 28, 2026	NCT07900633	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3,000	Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary...	clinicaltrials.gov
October 28, 2026	NCT07900373	Echinocandin Added to Standard Treatment for Severe Pneumocystis Pneumonia	McGill University Health Centre/Research Institute of the McGill University Health Centre	Phase 3	Not yet recruiting	Pneumocystis Jirovecii Pneumonia	416	Canada	clinicaltrials.gov
October 28, 2026	NCT07900061	Modified Short-Course Radiotherapy Combined With Tislelizumab and CAPOX for pMMR/MSS Rectal Cancer	Sir Run Run Shaw Hospital	Phase 3	Not yet recruiting	Rectal Cancer	210		clinicaltrials.gov
October 27, 2026	NCT07899307	Metformin in Acute Ischemic Stroke	All India Institute of Medical Sciences	Phase 3	Not yet recruiting	Acute Ischemic Stroke	440	India	clinicaltrials.gov
October 27, 2026	NCT07899164	Efficacy of Propranolol in Traumatic Brain Injury Patients Admitted to the ICU: A Prospective, Randomized, Triple-Blind Study	Fundació d'investigació Sanitària de les Illes Balears	Phase 3	Recruiting	Traumatic Brain Injury (TBI) Patients	536	Spain	clinicaltrials.gov
October 27, 2026	NCT07899073	A Study to Evaluate Efficacy and Safety of HIP2602 in Erectile Dysfunction Patients	Hanmi Pharmaceutical Company Limited	Phase 3	Recruiting	Erectile Dysfunction	225	South Korea	clinicaltrials.gov
October 27, 2026	NCT07898943	Evaluation of the Effect of Antibiotic Prophylaxis During Lumpectomy for Breast Cancer: Prospective Randomised Double-blind Noninferiority...	University Hospital, Clermont-Ferrand	Phase 3	Not yet recruiting	Breast Cancer, Breast Surgery, Surgical Site Infection (SSI), Surgical Site Infection Prevention	1,600	France	clinicaltrials.gov
October 27, 2026	NCT07898774	A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant...	Swedish Orphan Biovitrum	Phase 3	Recruiting	C3 Glomerulopathy (C3G), Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN), Recurrent...	30	Brazil, Canada, Finland, France, Germany, Italy, Saudi Arabia, Spain...	clinicaltrials.gov
October 27, 2026	NCT07898761	Bovine Colostrum In The Treatment Of Severe Alcohol-Associated Hepatitis	Dayanand Medical College and Hospital	Phase 3	Completed	Alcoholic Hepatitis	174	India	clinicaltrials.gov
October 27, 2026	NCT07898462	A Trial of Adjunctive Fludrocortisone (50mcg, 100mcg or Placebo) in Critically Ill Patients With Septic Shock Receiving Hydrocortisone...	The George Institute	Phase 3	Recruiting	Septic Shock	2,200	Australia	clinicaltrials.gov
October 27, 2026	NCT07898072	Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With Hypogonadism	Amneal Pharmaceuticals, LLC	Phase 3	Recruiting	Male Hypogonadism	190	United States	clinicaltrials.gov
October 27, 2026	NCT07898033	1 Year Recurrence After Modified en Bloc Resection (ERBT) vs Transurethral Resection (TURBT) for Large Bladder Tumors	dmitry enikeev	Phase 3	Recruiting	NMIBC, TCC	136	Israel	clinicaltrials.gov
October 27, 2026	NCT07897630	Suprachoroidal Bevacizumab Versus Intravitreal Bevacizumab in Diabetic Macular Edema	Khyber Teaching Hospital	Phase 3	Enrolling by invitation	Diabetic Macular Edema (DME)	60	Pakistan	clinicaltrials.gov
October 27, 2026	NCT07897188	ASKC202 Plus Limertinib as the First-line Therapy for Patients With EGFRm+/MET+ Locally Advanced or Metastatic NSCLC	Jiangsu Aosaikang Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	EGFR Activating Mutation, Non-Squamous Non-Small Cell Lung Cancer (NSCLC), MET Positive	425	China	clinicaltrials.gov
October 27, 2026	NCT07896590	Orelabrutinib Plus ICP 248 vs Orelabrutinib for Relapsed/Refractory Marginal Zone Lymphoma	Beijing InnoCare Pharma Tech Co., Ltd.	Phase 3	Not yet recruiting	Relapsed/Refractory Marginal Zone Lymphoma (MZL)	292	China	clinicaltrials.gov
October 27, 2026	NCT07896434	A Study to Learn How Effective, Safe, and Tolerable Upadacitinib is for Young Participants With Non-segmental Vitiligo	AbbVie	Phase 3	Not yet recruiting	Non-Segmental Vitiligo	154		clinicaltrials.gov
October 26, 2026	NCT07896265	Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes	Regeneron Pharmaceuticals	Phase 3	Not yet recruiting	Overweight or Obesity Without Diabetes	3,000		clinicaltrials.gov
October 26, 2026	NCT07896005	A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing Non-squamous Non-small Cell Lung Cancer	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Phase 3	Not yet recruiting	Non Small Cell Lung Cancer	436	China	clinicaltrials.gov
October 26, 2026	NCT07895992	SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a...	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Phase 3	Not yet recruiting	Non-squamous Non-small Cell Lung Cancer	490	China	clinicaltrials.gov
October 26, 2026	NCT07895732	Personalized Adaptive Radiotherapy for Hepatocellular Carcinoma	University Health Network, Toronto	Phase 3	Not yet recruiting	Hepatocellular Carcinoma (HCC)	60	Canada	clinicaltrials.gov
October 26, 2026	NCT07895238	A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLC	West China Hospital	Phase 3	Not yet recruiting	Non-small Cell Lung Cancer (NSCLC)	1,088		clinicaltrials.gov
October 26, 2026	NCT07895082	Quanduzhong Capsules for Primary Osteoporosis	Shanghai University of Traditional Chinese Medicine	Phase 3	Enrolling by invitation	Primary Osteoporosis	300	China	clinicaltrials.gov
October 26, 2026	NCT07894861	Efficacy and Safety of Maximum Labeled Dose Luspatercept in Lower-Risk Myelodysplastic Syndromes	Institute of Hematology & Blood Diseases Hospital, China	Phase 3	Not yet recruiting	Myelodysplastic Syndromes	75		clinicaltrials.gov
October 26, 2026	NCT07894484	Lactium Premedication to Prevent Emergence Agitation	Tanta University	Phase 3	Recruiting	Lactium, Premedication, Emergence Agitation, Adenotonsillectomy, Dose Finding Study	40	Egypt	clinicaltrials.gov
October 26, 2026	NCT07894328	A Phase III Clinical Study of HRS-6209 Plus Letrozole as First-line Therapy in Patients With Advanced or Metastatic Breast Cancer	Jiangsu HengRui Medicine Co., Ltd.	Phase 3	Not yet recruiting	Breast Cancer	1,050	China	clinicaltrials.gov
October 26, 2026	NCT07894211	QLC5508 vs. Investigator's Choice Chemotherapy in Advanced Extrapulmonary Neuroendocrine Carcinoma	Qilu Pharmaceutical Co., Ltd.	Phase 3	Not yet recruiting	Extrapulmonary Neuroendocrine Carcinoma	270		clinicaltrials.gov
October 23, 2026	NCT07893275	SGB for Prevention of Postop A-Fib After Cardiac SurgeryTrial	The Cleveland Clinic	Phase 3	Not yet recruiting	Atrial Fibrillation, Postoperative Atrial Fibrillation	60		clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
AstraZeneca	61	November 6, 2026
Pfizer	54	November 9, 2026
Eli Lilly and Company	49	October 28, 2026
GlaxoSmithKline	47	October 13, 2026
Sun Yat-sen University	40	October 29, 2026
Qilu Pharmaceutical Co., Ltd.	37	November 9, 2026
Sanofi	37	November 5, 2026
Assistance Publique - Hôpitaux de Paris	35	November 4, 2026
Merck Sharp & Dohme LLC	34	November 2, 2026
Fudan University	34	October 16, 2026
Novo Nordisk A/S	32	November 5, 2026
Colgate Palmolive	31	November 4, 2026
Novartis Pharmaceuticals	31	September 30, 2026
Hoffmann-La Roche	30	November 5, 2026
Assiut University	30	November 3, 2026
Ain Shams University	28	November 4, 2026
Amgen	27	October 13, 2026
Cairo University	25	November 5, 2026
Janssen Research & Development, LLC	24	October 30, 2026
AbbVie	23	October 27, 2026

Conditions

Condition group	New trials	Latest
Obesity	144	November 6, 2026
Breast Neoplasms	108	November 4, 2026
Overweight	99	November 6, 2026
Carcinoma, Non-Small-Cell Lung	88	November 2, 2026
Diabetes Mellitus, Type 2	87	November 6, 2026
Ischemic Stroke	79	November 3, 2026
Prostatic Neoplasms	45	October 30, 2026
Neoplasms	44	October 13, 2026
Multiple Myeloma	37	November 2, 2026
Depressive Disorder, Major	37	August 24, 2026
Colorectal Neoplasms	35	November 3, 2026
Stroke	35	October 15, 2026
Ovarian Neoplasms	32	November 9, 2026
Pain, Postoperative	32	October 19, 2026
Heart Failure	30	November 6, 2026
Dermatitis, Atopic	30	November 5, 2026
Hypertension	28	November 5, 2026
Agnosia	27	November 2, 2026
Pain	27	October 19, 2026
Alzheimer Disease	27	August 7, 2026
Leukemia, Myeloid, Acute	26	November 9, 2026
Pulmonary Disease, Chronic Obstructive	26	October 30, 2026
Renal Insufficiency, Chronic	26	October 22, 2026
Asthma	26	October 9, 2026
Pancreatic Neoplasms	25	September 16, 2026

By country

Country	New trials	Latest
China	1,259	November 9, 2026
United States	1,165	November 9, 2026
Spain	508	November 5, 2026
France	491	November 4, 2026
Canada	475	November 5, 2026
Germany	464	November 5, 2026
Italy	426	November 5, 2026
United Kingdom	416	November 5, 2026
Japan	411	November 5, 2026
Poland	395	November 5, 2026
Australia	366	November 5, 2026
South Korea	355	November 5, 2026
Brazil	317	November 5, 2026
Taiwan	264	November 4, 2026
Argentina	262	November 5, 2026
Belgium	255	November 5, 2026
Netherlands	254	November 5, 2026
Czechia	232	November 4, 2026
Hungary	206	November 5, 2026
Greece	192	October 21, 2026
Turkey (Türkiye)	184	October 28, 2026
Mexico	173	November 4, 2026
India	168	November 6, 2026
Denmark	166	November 5, 2026
Romania	165	November 4, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.